Elahere Interactions
There are 121 drugs known to interact with Elahere (mirvetuximab soravtansine), along with 4 disease interactions. Of the total drug interactions, 28 are major, and 93 are moderate.
- View all 121 medications that may interact with Elahere
- View Elahere disease interactions (4)
Most frequently checked interactions
View interaction reports for Elahere (mirvetuximab soravtansine) and the medicines listed below.
- Allegra Allergy (fexofenadine)
- amlodipine
- carvedilol
- Colace (docusate)
- diazepam
- Doxil (doxorubicin liposomal)
- Enhertu (fam-trastuzumab deruxtecan)
- gabapentin
- Gemzar (gemcitabine)
- glipizide
- hydrocortisone
- insulin glargine
- Janumet (metformin / sitagliptin)
- magnesium oxide
- meclizine
- methimazole
- Mylotarg (gemtuzumab)
- ondansetron
- pantoprazole
- Pepcid AC Chewable Tablets (famotidine)
- Pepcid AC Maximum Strength (famotidine)
- rosuvastatin
- sulfamethoxazole / trimethoprim
- valsartan
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Zofran (ondansetron)
- Zynlonta (loncastuximab tesirine)
Elahere disease interactions
There are 4 disease interactions with Elahere (mirvetuximab soravtansine) which include:
More about Elahere (mirvetuximab soravtansine)
- Elahere consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.